Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (461-470 of 771) with videos related to

Pageof 78
Sort By:
The American Journal of Cardiology|December 26, 2007
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, Karen Chiswell, Jie-Lena Sun, et al.
Journal of the American College of Cardiology|May 10, 2008
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or bothL Michael Prisant, Kevin L Thomas, Eldrin F Lewis, et al.
Critical Care Medicine|December 24, 2009
Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomesJason N Katz, Bimal R Shah, Elizabeth M Volz, et al.
Journal of the American Society of Nephrology : JASN|August 26, 2003
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery diseaseDonal N Reddan, Lynda Anne Szczech, Robert H Tuttle, et al.
American Heart Journal|June 25, 2005
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationaleRobert P Giugliano, L Kristin Newby, Robert A Harrington, et al.
The American Journal of Cardiology|November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2008
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgeryRajendra H Mehta, Gail E Hafley, C Michael Gibson, et al.
The American Journal of Cardiology|September 6, 2018
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure StatusAndrew P Ambrosy, Lukasz P Cerbin, Marat Fudim, et al.
American Heart Journal|March 29, 2008
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialRachel E Anderson, Marc A Pfeffer, Jens Jakob Thune, et al.
American Heart Journal|August 9, 2005
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trialE Magnus Ohman, Frans Van de Werf, Elliott M Antman, et al.
Pageof 78

Showing results (461-470 of 771) with videos related to

Sort By:
Pageof 78
The American Journal of Cardiology|December 26, 2007
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, Karen Chiswell, Jie-Lena Sun, et al.
Journal of the American College of Cardiology|May 10, 2008
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or bothL Michael Prisant, Kevin L Thomas, Eldrin F Lewis, et al.
Critical Care Medicine|December 24, 2009
Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomesJason N Katz, Bimal R Shah, Elizabeth M Volz, et al.
Journal of the American Society of Nephrology : JASN|August 26, 2003
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery diseaseDonal N Reddan, Lynda Anne Szczech, Robert H Tuttle, et al.
American Heart Journal|June 25, 2005
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationaleRobert P Giugliano, L Kristin Newby, Robert A Harrington, et al.
The American Journal of Cardiology|November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2008
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgeryRajendra H Mehta, Gail E Hafley, C Michael Gibson, et al.
The American Journal of Cardiology|September 6, 2018
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure StatusAndrew P Ambrosy, Lukasz P Cerbin, Marat Fudim, et al.
American Heart Journal|March 29, 2008
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialRachel E Anderson, Marc A Pfeffer, Jens Jakob Thune, et al.
American Heart Journal|August 9, 2005
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trialE Magnus Ohman, Frans Van de Werf, Elliott M Antman, et al.
Pageof 78